Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

CONTEXT: The prevalence of autoimmune disorders in individuals with 21-hydroxylase deficiency (21OHD) is unclear. The gene responsible, CYP21A2, is located in a highly immunologically active region. OBJECTIVE: To study the prevalence of autoimmune disorders in individuals with 21OHD. DESIGN, SETTING...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Falhammar, Henrik, Frisén, Louise, Hirschberg, Angelica Linden, Nordenskjöld, Agneta, Almqvist, Catarina, Nordenström, Anna
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497917/
https://ncbi.nlm.nih.gov/pubmed/31065621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00122
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars